INTRODUCTION {#S1}
============

The vast majority of infection studies is conducted in specific pathogen-free laboratory animals that are challenged with individual pathogens. In striking contrast, a history of infection with multiple pathogens is common in humans, especially in developing countries.^[@R1]^ Concurrent infections elicit complex immune responses which can potentially interfere with host immunity to secondary pathogen challenge.^[@R1]--[@R9]^ This consideration is particularly relevant for chronic infections such as helminthiases, which elicit potent immune responses with lasting effects on the immune status.^[@R8]--[@R11]^ While helminth parasites typically establish chronic infection, they are generally tolerated with limited immunopathology, presumably owing to potent immunomodulatory effects.^[@R11],[@R12]^ However, as a negative consequence of immunomodulation, parasitized individuals are generally considered to be more susceptible to secondary infection.^[@R1]--[@R7]^

Infection with helminth parasites elicits robust Th2-polarized CD4 T cell responses with IL-4 as a critical effector cytokine.^[@R11],[@R13]^ In contrast to CD4 T cells, CD8 T cells have no apparent impact on the immunological or parasitological parameters.^[@R14]^ Consequently, few studies have analyzed CD8 T cell responses to helminth infection.^[@R15],[@R16]^ Recently, a minor CD8 T cell population of so-called "virtual memory" CD8 T (CD8 T~VM~) cells has been described.^[@R17]--[@R25]^ These cells arise naturally in naive mice housed under specific pathogen-free and germfree conditions without the exposure to foreign Ag, and display the phenotype and function of Ag-experienced "true" memory CD8 T cells.^[@R21],[@R22]^ Namely, CD8 T~VM~ cells rapidly produce IFNγ upon TCR stimulation or in response to the cytokines IL-12 and IL-18. They have also been shown to confer Ag-specific protection against *Listeria monocytogenes* (*Lm*) infection.^[@R18]--[@R20]^ However, whether CD8 T~VM~ cells can provide non Ag-specific protection is controversial.^[@R20],[@R26]^ While Jameson and colleagues conclude that neither virtual nor true memory transgenic CD8 T cells confer non-cognate protection against wild-type *Lm* infection,^[@R20]^ Kedl and colleagues have shown that transgenic CD8 T~VM~ cells with irrelevant antigen specificity can mediate bystander protection against *Lm* infection.^[@R26]^

It has been shown that IL-4 produced by natural killer T (NKT) cells can drive the generation of CD8 T~VM~ cells under steady-state condition in the absence of foreign Ag.^[@R23],[@R24]^ This type of CD8 T~VM~ cell is abundant in BALB/c mice but less so in C57BL/6 mice,^[@R23]^ presumably correlating with the relative abundance of IL-4-producing NKT cells in the respective strains. To date, however, it has not been explored whether IL-4 responses generated by helminth infection or immunization regulate the CD8 T~VM~ population in a "bystander" fashion, and whether these cells could provide non-cognate innate protection against infections with unrelated pathogens. In this study, we provide fundamentally new insight into the biology of virtual memory CD8 T cells in the context of IL-4-dominated immune responses to helminth infection or immunization, and reveal their previously unknown protective potential against subsequent unrelated infection.

RESULTS {#S2}
=======

Helminth infection confers protection against subsequent bacterial infection {#S3}
----------------------------------------------------------------------------

To examine the effects of helminth infection on subsequent bacterial challenge, we infected C57BL/6 (B6) mice with the strictly enteric parasite *Heligmosomoides polygurus* (*Hp*), drug-cured the animals after 2 weeks, and infected them intraperitoneally with the Gram-positive bacterium *Lm* 1 week later. In contrast to considerable epidemiological evidence and animal model studies indicating that helminth infection increases susceptibility to viral and bacterial infection,^[@R1]--[@R5],[@R8]^ we found that mice previously infected with *Hp* showed significantly improved survival after challenge with *Lm* compared with their *Hp*-uninfected counterparts ([Figure 1a](#F1){ref-type="fig"}). *Hp*-cured mice also showed significantly reduced bacterial burden in the liver at day 3 after infection ([Figure 1b](#F1){ref-type="fig"}). Consistent with the survival data, 3 out of 10 naïve controls had succumbed to *Lm* infection while all *Hp*-cured mice survived until analysis at day 3 ([Figure 1b](#F1){ref-type="fig"}). Even more pronounced protection was observed when *Hp*-cured mice were challenged orally with the enteric Gram-negative bacterium *Yersinia pseudotuberculosis* (*Yp*) ([Figure 1c](#F1){ref-type="fig"}). *Hp*-cured mice were significantly protected against *Yp* infection with nearly 50% of the mice surviving the lethal *Yp* challenge with an overall 11-day prolongation in median survival time as compared with naïve controls.

Virtual memory CD8 T cells expand during helminth infection {#S4}
-----------------------------------------------------------

To investigate the possibility that the IL-4-dominated Th2 response to helminth infection drives the generation of CD8 T~VM~ cells, we inoculated B6 IL-4 reporter mice with *Hp* and analyzed the draining mesenteric LN (mesLN) 2 weeks later. As expected ^[@R13]^, the infection elicited a robust CD4 effector (CD44^hi^CD62L^lo^) T cell response with an abundance of IL-4 (IL-4/GFP^+^) ([Figure 2a](#F2){ref-type="fig"}). Although CD8 T cells have reportedly no appreciable impact on the immunological or parasitological parameters,^[@R14]^ unexpectedly, we detected a substantially increased frequency of central memory (CD44^hi^CD62L^hi^) but not effector (CD44^hi^CD62L^lo^) phenotype CD8 T cells in *Hp*-infected mice ([Figure 2b](#F2){ref-type="fig"}). These CD44^hi^CD62L^hi^ cells were further identified as CD8 T~VM~ cells based on a CD49d^lo^ phenotype ([Figure 2b](#F2){ref-type="fig"}).^[@R18],[@R25]^ Over the course of infection, CD8 T~VM~ cells (CD44^hi^CD49d^lo^) expanded first in the draining mesLN around day 5 concurrent with the onset of the Th2/IL-4 response ([Figure 2c](#F2){ref-type="fig"});^[@R13]^ and then disseminated systemically to non-reactive secondary lymphoid organs, a migration pattern consistent with their CD62L^hi^ phenotype. The frequency and number of CD8 T~VM~ cells remained significantly elevated for prolonged periods, even when the mice were drug-cured 2 weeks after infection ([Figure 2d](#F2){ref-type="fig"}). Moreover, the increase of CD49d^lo^ CD8 T~VM~ cells occurred in both B6 mice and BALB/c mice infected with *Hp* ([Figure 2f](#F2){ref-type="fig"}). Notably, while CD44 was clearly upregulated on activated CD4 T cells in both B6 and BALB/c mice ([Figure 2a,e](#F2){ref-type="fig"}), CD8 T cells in BALB/c mice failed to display a distinctive shift of CD44 expression ([Figure 2f](#F2){ref-type="fig"}, upper panels), and CD8 T~VM~ cells can only be unambiguously identified by the downregulation of CD49d ([Figure 2f](#F2){ref-type="fig"}, lower panels). Since BALB/c mice are widely used in helminth disease models, this might explain, at least in part, why the activation of CD8 T cells has largely been unnoticed in that setting. The increased frequency of CD8 T~VM~ cells in BALB/c mice compared with B6 mice correlated with an increased frequency of IL-4/GFP+ cells in the mesLN of naive and *Hp*-infected mice ([Figure 2g,h](#F2){ref-type="fig"}). Our data reveal that CD8 T~VM~ cells expanded during helminth infection. The origin of the CD8 T~VM~ cell expansion in the IL-4-rich mesLN,^[@R13]^ its kinetics, and the comparison of IL-4/Th2-biased BALB/c to B6 mice, together suggest that the abundance of CD8 T~VM~ cells is regulated by the production of IL-4 in this model.

The expansion of CD8 T~VM~ cell is dependent on direct IL-4 signals {#S5}
-------------------------------------------------------------------

To explore whether other IL-4-associated Th2 responses would also result in a CD8 T~VM~ cell expansion, we immunized B6 IL-4 reporter mice subcutaneously into the footpad with *Schistosoma mansoni* eggs or 4-hydroxy-3-nitrophenylacetyl-KLH (NP-KLH) in alum. Both agents induced robust Th2/IL-4 responses in the draining popliteal LN and resulted in a significantly increased frequency of CD8 T~VM~ cells ([Figure 3a](#F3){ref-type="fig"}). Of note, the extent of the CD8 T~VM~ cell expansion correlated with the frequency of IL-4^+^ cells, further supporting the hypothesis that IL-4 governs the expansion of CD8 T~VM~ cells. To explore this further, we activated glycolipid-specific invariant NKT (iNKT) cells, potent producers of IL-4,^[@R27]^ by intravenous administration of the glycolipid, non-protein antigen α Galactosyl ceramide (αGalCer). The administration of αGalCer to B6 wild-type (WT) mice but not iNKT-deficient CD1d KO mice resulted in an increased frequency ([Figure 3b](#F3){ref-type="fig"}) and number (data not shown) of CD8 T~VM~ cells. Notably, even under steady-state conditions CD8 T~VM~ cells were significantly reduced in naïve CD1d KO mice ([Figure 3b](#F3){ref-type="fig"}), corroborating previous studies that iNKT cells contribute to the regulation of the CD8 T~VM~ abundance, potentially by production of IL-4.^[@R23],[@R24]^ As expected, CD8 T~VM~ cells were also significantly reduced in naive and αGalCer-immunized IL-4 KO B6 mice ([Figure 3c](#F3){ref-type="fig"}), demonstrating a critical role for IL-4 in driving the expansion of CD8 T~VM~ pool. Interestingly, CD8 T~VM~ cells expanded in IL-4 KO B6 mice upon αGalCer immunization to some degree, revealing a partially IL-4-independent mechanism. Together, our data suggests that IL-4 production elicited by diverse immune stimuli in various sites results in the expansion of the CD8 T~VM~ pool.

To revisit the role of IL-4 in the expansion of CD8 T~VM~ cells during natural infection, we challenged WT and IL-4 KO mice on B6 and BALB/c backgrounds with *Hp*. CD8 T~VM~ cells were significantly reduced in naive and *Hp*-infected IL-4 KO mice on both genetic backgrounds ([Figure 3d](#F3){ref-type="fig"}). Interestingly, while CD8 T~VM~ cells in IL-4 KO mice on the B6 background showed a partial expansion upon *Hp* infection, they did not expand in IL-4 KO mice on the BALB/c background. Similar outcomes were also observed in IL-4 receptor α chain (IL-4Rα) KO and signal transducer and activator of transcription (STAT) 6 KO mice on the BALB/c background (data not shown). This suggests that the expansion of CD8 T~VM~ cells in BALB/c mice is strictly dependent on IL-4 and IL-4Rα whereas both IL-4- or IL-4Rα-deficiency can partially be compensated by alternative pathways in B6 mice infected with *Hp* or immunized with αGalCer.

To establish whether the CD8 T~VM~ population is regulated by direct IL-4Rα signals, we generated B6 and BALB/c radiation chimeras reconstituted with equal parts of genetically marked WT and IL-4Rα KO bone marrow (BM) cells. As shown in [Fig. 3e](#F3){ref-type="fig"}, the frequency of CD8 T~VM~ cells was significantly reduced in IL-4Rα KO CD8 T cells in both naïve and *Hp*-infected chimeras on both genetic backgrounds. Consistent with the IL-4 KO data ([Figure 3d](#F3){ref-type="fig"}), IL-4Rα KO cells in B6 mice showed a partial expansion of CD8 T~VM~ cells upon *Hp* infection but remained significantly reduced compared to their WT counterparts in the same animal, whereas IL-4Rα KO CD8 T~VM~ cells in BALB/c mice did not expand at all ([Figure 3e](#F3){ref-type="fig"}). Together, these data reveal that direct IL-4Rα signals regulate the size of CD8 T~VM~ pool in naive animals and upon IL-4-dominated Th2 responses to immunization or infection. However, the extent to which IL-4 and IL-4Rα signals govern the expansion depends on the genetic background. While the expansion of CD8 T~VM~ cell in BALB/c mice is strictly dependent on IL-4 and IL-4Rα, alternative pathways can partially compensate for IL-4 and IL-4Rα in B6 mice.

The expansion of CD8 T~VM~ cell is independent of cognate antigen {#S6}
-----------------------------------------------------------------

The robust expansion of CD8 T~VM~ cells without apparent effector cell differentiation ([Figure 2b,f](#F2){ref-type="fig"}) suggests that CD8 T~VM~ cells do not encounter cognate antigen during this process. Moreover, CD8 T~VM~ cells also expanded without the administration of exogenous protein antigen when iNKT cells were selectively activated by αGalCer ([Figure 3b,c](#F3){ref-type="fig"}). To follow a population of CD8 T cells of defined, infection-irrelevant specificity, we transfer OT-I TCR transgenic CD8 T cells specific for OVA~257--264~ into CD45.1^+^ congenic B6 WT mice, and infected the recipients with *Hp* the following day. Like in the polyclonal host CD8 T~VM~ cell population, *Hp* infection resulted in a marked increase in the frequency and number of CD8 T~VM~ cells in the OT-I population as well ([Figure 4](#F4){ref-type="fig"}). This indicates that the expansion of CD8 T~VM~ cells during *Hp* infection is independent of cognate antigen. Collectively, our data support a model whereby the expansion of CD8 T~VM~ cells upon IL-4-dominant immune responses to infection or immunization occurs independent of the encounter with cognate antigen and is driven predominantly by cytokine.

CD8 T~VM~ cells are sufficient to confer innate non-cognate protection against bacterial infection {#S7}
--------------------------------------------------------------------------------------------------

CD8 T~VM~ cells share many functional features with antigen-experienced "true memory" CD8 T cells, including rapid IFNγ production upon TCR stimulation and confer Ag-specific protection against infection.^[@R18]--[@R20]^ Moreover, they both produce IFNγ in response to the innate cytokines IL-12 and IL-18.^[@R18]^ It has been shown that Ag-experienced memory CD8 T cells can provide IFNγ-dependent protection against *Lm* infection in the absence of cognate Ag.^[@R28]^ Along with the observations that helminth infection provided increased resistance against bacterial challenge ([Figure 1](#F1){ref-type="fig"}) and induced robust expansion of CD8 T~VM~ cells ([Figure 2](#F2){ref-type="fig"}), we consider the possibility that CD8 T~VM~ cells expanded during helminth infection contribute to the non-cognate protection against unrelated bacteria. Since *Hp* infection elicits extensive immunological and physiological changes in the parasitized host, in order to definitively demonstrate that CD8 T~VM~ cells directly contribute to the increased protection, and to explore whether CD8 T~VM~ cells alone are sufficient to confer protection, we sorted naïve (CD44^lo^) and CD8 T~VM~ (CD44^hi^CD49d^lo^) cells from the same *Hp*-infected donors and transferred them separately into naïve recipients ([Figure 5](#F5){ref-type="fig"}). To avoid the possibility that IFNγ produced by host cells masks the potential protective impact of the transferred CD8 T cells, we used IFNγ KO recipients.^[@R28]^ As shown in [Figure 5](#F5){ref-type="fig"}, transfer of CD8 T~VM~ cells but not naïve CD8 T cells from the same donor reduced the bacterial burden at least 10-fold in both liver and spleen, demonstrating that CD8 T~VM~ cells expanded during helminth infection not only directly contribute to but also suffice to confer innate non-cognate protection against bacterial challenge.

DISCUSSION {#S8}
==========

While the signature Th2 cytokine IL-4 has previously been linked to the expansion of memory phenotype CD8 T cells^[@R15],[@R29],[@R30]^ and the size of the CD8 T~VM~ pool under steady-state conditions,^[@R23],[@R24],[@R31]^ to our knowledge, we are the first to describe that Th2 responses to helminth infection or immunization result in the antigen-independent systemic "bystander" expansion of CD8 T~VM~ cells in both B6 and BALB/c mice. The expansion of CD8 T~VM~ cells was strictly dependent on IL-4 and direct IL-4Rα signals in BALB/c mice; interestingly, it was partially IL-4 and IL-4Rα-independent in B6 mice ([Figure 3c,e](#F3){ref-type="fig"}). Since the IL-4Rα chain is indispensable for IL-13 signaling mediated exclusively by the type II IL-4 receptor complex, IL-13 cannot compensate for IL-4 in IL-4Rα-deficient B6 mice. ^[@R32]--[@R34]^ This conclusion is consist with the general understanding that T cells do not express the IL-13Rα1 chain and do not respond to IL-13, ^[@R32],[@R34]^ although it has been shown that Th17 polarized CD4+ T cells, but no other T cell subsets, can express a functional IL-13 receptor. ^[@R35]^ Therefore, our data suggest that the expansion of CD8 T~VM~ cell after helminth infection is dominantly dependent on IL-4. In support of our conclusion, it has been reported that the administration of IL-4/anti-IL-4 antibody complexes into naïve B6 mice as well as OT-I TCR transgenic mice could induce the generation of memory-like CD8 T cell in the periphery. ^[@R36]^ It is conceivable that IL-15---which is also critical for CD8 T~VM~ cell development and can induce the expansion of CD8 T~VM~ cells *in vivo*^[@R25],[@R26],[@R37]^ --- could partially compensate the absence of IL-4 or IL-4Rα, particularly when diverse cellular subsets are engaged during complex immune responses to infections ([Figure 2d,e](#F2){ref-type="fig"}). However, it is less clear how this occurs upon the selective activation of iNKT cells by αGalCer ([Figure 2c](#F2){ref-type="fig"}). Nevertheless, how alternative pathway(s) are activated in the diverse settings of Th2 immunity and why it is limited to the B6 background warrants further investigation.

More intriguingly, our data presented here provide direct evidence that CD8 T~VM~ cells expanded during helminth infection are in turn sufficient to increase resistance to bacterial challenge, suggesting that they can confer enhanced non-cognate protection in helminth-infected mice. This unexpected CD8 T~VM~-mediated non-cognate protection is broadly effective against infection with both Gram-negative and Gram-positive bacteria via different routes. Notably, the protection conferred by CD8 T~VM~ cells is not as potent as that provided by antigen-specific virtual or true memory T cells.^[@R19],[@R20]^ However, considering its innate-like non Ag-specific feature, we speculate that the IL-4-mediated expansion of CD8 T~VM~ cells during helminth infection has evolved to provide broad "collateral protection" against diverse secondary infections in an Ag independent manner. Furthermore, our data show that IL-4-inducing adjuvants, such as the routinely used alum, one of the only two FDA-approved adjuvants, increase the abundance of CD8 T~VM~ cells and subsequently have a profound impact on the systemic CD8 T cell population. It stands to reason that IL-4-associated asthmatic and allergic disorders may have a similar effect on CD8 T~VM~ cells and the systemic CD8 T cell pool.

It is worth noting that in published studies the protective potential of CD8 T~VM~ cells was typically tested in model infections such as Lm and lymphocytic choriomeningitis virus (LCMV) in relatively clean systems that only involved CD8 T~VM~ cells.^[@R19],[@R20],[@R26],[@R37],[@R38]^ The protection was suggested to be mediated by the production of IFNγ by CD8 T~VM~ cells.^[@R18]^ In contrast, helminth infection elicits complex immune responses, and the impact on the subsequent infection was tested in various infection models with various combinations of pathogens. Therefore, the reported outcomes were highly diverse and likely highly context dependent. While most studies conclude that helminthiases negatively impact immunity to concurrent and/or subsequent bacterial or viral infection,^[@R1]--[@R7]^ there are also reports of either positive effects^[@R39],[@R40]^ or no impact.^[@R7],[@R41],[@R42]^ The mechanism(s) underlying this discrepancy remain poorly understood, and could be specific for particular infection models, different combinations of pathogens, different timing or route of infection, or a number of other factors. Consequently, care must be taken when interpreting and comparing these results. Nonetheless, our data demonstrate that prior *Hp* infection can increase host resistance to subsequent bacterial infections. To the best of our knowledge, we are the first to suggest that helminth-mediated effects could provide survival advantage to subsequent unrelated infections through the expansion of CD8 T~VM~ cells. However, while we demonstrated in a transfer model that CD8 T~VM~ cells expanded upon helminth infection suffice to reduce bacterial burden, we did not rule out the possibility that other factors may also contribute to the enhanced protection in *Hp*-infected mice. Moreover, the defense mechanisms that control subsequent infections may vary between pathogens. Thus, in some infectious contexts, the protective potential of CD8 T~VM~ cells may not be relevant or may be counteracted by other profound mechanisms. Potential mechanisms by which bystander infection may affect immune responses to unrelated pathogens have been discussed.^[@R1],[@R43]^ Further studies will be required to investigate the difference between beneficial and detrimental effects, as well as to determine other potential factors enhancing protection observed in our model.

Recently, awareness has grown regarding the shortcomings of mouse models in studying immune responses to infections.^[@R43],[@R44]^ While laboratory mice are deliberately housed under specific pathogen-free conditions, humans acquire a diverse and individual history of acute and chronic infections throughout life. The interplay between different pathogens and the immune responses they elicit are complex. Consequently, while the infection history of an individual is a likely determinant of immune responses, it is also a potential confounding factor in studying and understanding immune responses to subsequent infection. The sequential infection of mice with multiple pathogens may allow modeling these events to study the complex interactions that can translate to humans.^[@R43],[@R44]^ Indeed, broad "collateral protection" resulting from an individual's immunological history might be widespread, particularly in helminth endemic areas where exposure to secondary infection is common, and in populations where children received alum-based vaccines. Harnessing the protective reality of virtual memory CD8 T cells might open new avenues for prophylactic and therapeutic intervention.

METHODS {#S9}
=======

Mice. {#S10}
-----

Wild-type mice were on both the C57BL/6 and the BALB/c background, as were IL-4reporter mice, B6.129-*Il4*^*tm1Lky*^/J and C.129-*Il4*^*tm1Lky*^/J, respectively.^[@R45],[@R46]^ IL-4 KO and IL-4RαKO^[@R33]^ mice were also on both the C57BL/6 and the BALB/c background. CD1d KO (B6(C)-*Cd1d1*/*Cd1d2*^*tm1.2Aben*^/J), IFNγ KO (B6.129S7-*Ifng4*^*tm1Ts*^), and OT-I TCR transgenic mice specific for OVA~257--264~ in the context of H2K^b^ (C57BL/6-Tg(TcraTcrb)1100Mjb/J) were on the C57BL/6 background. CD45.1 congenic mice (B6.SJL-*Ptprc*^*a*^*Pepc*^*b*^*/BoyJ*) were on the C57BL/6 background, and Thy1.1 congenic mice (CBy.PL(B6)-*Thy1*^*a*^/ScrJ) were on the BALB/c background. Animals were bred and kept under specific pathogen-free conditions at the Trudeau Institute and were used at 8--12 weeks of age. All experiments were performed under Institutional Animal Care and Use Committee-approved protocols at the Trudeau Institute.

Infections and immunizations. {#S11}
-----------------------------

Animals were infected by gavage with 200 third-stage larvae of *Hp* as previously described.^[@R45]^ Where indicated, mice were treated by gavage with the antihelminthic pyrantel pamoate (100 mg/kg) 2 weeks later to terminate *Hp* infection. One week later, mice were infected intraperitoneally with 2.5 × 10^6^ CFU of *Lm* (strain EGD) or 5 × 10^9^ CFU of *Yp* (serotype O:1 strain 32777) by gavage as previously described.^[@R47],[@R48]^ In some experiments, mice were injected with 2500 *S. mansoni* eggs (Puerto Rican strain NMRI) subcutaneously into the footpad. In other experiments, mice were immunized subcutaneously into the footpad with 100 µg of 4-hydroxy-3-nitrophenylacetyl-KLH (NP-KLH; Biosearch Technologies) precipitated in alum (Imject Alum; ThermoScientific), or intravenously with 0.5µg/mouse αGalactosylceramide (αGalCer) in PBS containing 0.1% BSA and \<0.25% DMSO, or solvent alone (PBS containing BSA and DMSO). Mice were sacrificed and cells were harvested and analyzed at the indicated times. For survival studies, mice were monitored in 12 hr intervals. Unresponsive or recumbent mice were considered moribund and euthanized. Bacterial burden in liver and spleen was determined at day 3 after *Lm* infection as previously described.^[@R47]^

Flow cytometry. {#S12}
---------------

Single cell suspensions were prepared from the mesenteric LN, non-draining LN (pooled inguinal, brachial and axillary), and spleen; then stained, acquired on a FACS Canto II (BD Biosciences) and analyzed using Flow Jo software (Tree Star, Inc.) as described.^[@R45]^ Dead cells were excluded from the analyses by the addition of propidium iodide (0.5 µg/ml; Sigma-Aldrich). The following mAbs were used and clone designations are given in parenthesis: CD4 (RM4--5), CD8α (53--6.7), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD49d (R1--2 or 9C10), CD62L (MEL-14), IL-4Rα (M1), Thy1.1 (HIS5), Thy1.2 (53--2.1), Vα2 (B20.1), Vβ5 (MR9--4).

Mixed bone marrow chimeras. {#S13}
---------------------------

Bone marrow cells from WT and IL-4Rα KO mice on either the B6 or BALB/c background were mixed at a 1:1 ratio, and a total of 1 × 10^7^ cells were injected intravenously into lethally irradiated (950 rad provided in two doses) WT recipients on the same background. Chimeric mice were allowed to immune-reconstitute for 6--8 week before they were infected with *Hp*.

CD8 T cell isolation and transfer. {#S14}
----------------------------------

CD8^+^ cells were enriched from the spleens and LN of OT-I TCR transgenic mice by B cell panning and 1 × 10^7^ cells were transferred intravenously into CD45.1 congenic hosts one day prior to *Hp* infection. To sort naïve (CD44^lo^) and CD8 T~VM~ (CD44^hi^CD49d^lo^) cells, B6 mice were infected with *Hp* and CD8 T cells from the mesLN and spleen were enriched by negative selection using magnetic activated cell sorting (MACS; Miltenyi Biotec Inc) according to the manufacturer's instruction. CD8-enriched samples were then stained for CD8α, CD44, and CD49d and the designated populations were sorted on an InFlux cell sorter (BD Biosciences). A total of 1--3 × 10^6^ cells of the respective populations were transferred intravenously into IFNγ KO recipients one day prior to *Lm* infection.

Statistical analysis. {#S15}
---------------------

Prism 5 (GraphPad Software) was used for statistical analysis. Data sets were compared by unpaired, two-tailed Student's *t* test or one-way ANOVA. Data are represented as mean ± SEM if not indicated otherwise. Survival data were analyzed by the log rank test. ns, not significant; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001.
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![Helminth infection provides protection against subsequent systemic and enteric bacterial infection. B6 WT mice were either uninfected or infected by gavage with 200 larvae of *Hp*, and cured with an antihelminthic after 2 weeks. (**a and b**) One week later, mice were challenged intraperitoneally with 2.5×10^6^ CFU of the Gram-positive bacterium *Lm*. (**a**) Survival was monitored in 12 hr intervals. Data were pooled from 3 independent experiments (n=30 per group). (**b**) Bacterial burden in the liver was determined at day 3 after *Lm* challenge. Data were pooled from 2 independent experiments. Solid bar depicts mean. X indicates individual mice that had succumbed to infection prior to analysis. (**c**) One week after drug cure, mice were challenged by gavage with 5×10^9^ CFU of the Gram-negative bacterium *Yp*. Survival was monitored in 12 hr intervals. (n=9 per group). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\*\**P* \< 0.0001 by log rank test (**a** and **b**) or Student's *t* test (**b**).](nihms-1508707-f0001){#F1}

![CD8 T~VM~ cells expand upon helminth infection. B6 (**a-d, g, h**) or BALB/c (**e-h**) IL-4 reporter mice were infected with *Hp*, and the draining mesLN, non-draining LN (ndLN) and spleen (Sp) were harvested at the indicated times and cells were analyzed by FACS. Plots and graphs were gated on CD4^+^ (**a, e, h**) or CD8α^+^ (**b-d, f, g**) cells. Data in (**d**) depict the mesLN. Data are representative of two or more independent experiments with three to five mice per group. Error bars depict the SEM. \*\*\**P* \< 0.001 by Student's *t* test.](nihms-1508707-f0002){#F2}

![The expansion of CD8 T~VM~ cells is dependent on direct IL-4 signal. (**a**) B6 IL-4 reporter mice were immunized with 2500 *S. mansoni* eggs or 100 µg NP-KLH/alum by injection into the footpad. The draining popliteal LNs were harvested 9 days later and analyzed as described in [Fig. 2](#F2){ref-type="fig"}. (**b** and **c**) B6 WT, CD1d KO **(b)** or IL-4 KO **(c)** mice were immunized intravenously with 0.5 µg αGalCer. Control mice were treated with solvent alone (PBS containing BSA and DMSO). The spleen was harvested 1 week later and CD8α^+^ T cells were analyzed as described in [Fig. 2](#F2){ref-type="fig"}. (**d**) WT or IL-4 KO mice in B6 or BALB/c background either remained uninfected or were infected with *Hp*. The mesLN cells were harvested 2 weeks later and analyzed as described in [Fig. 2](#F2){ref-type="fig"}. (**e**) Mixed BM chimeras were generated by reconstituting equal part of irradiated CD45.1^+^ B6 recipients with WT (CD45.1^+^) and IL-4Rα KO (CD45.2^+^) BM, or Thy1.1^+^ BALB/c recipients with WT (Thy1.1^+^) and IL-4Rα KO (Thy1.2^+^) BM. Reconstituted mice either remained uninfected or were infected with *Hp*. The mesLN cells were harvested 2 weeks later, and WT and IL-4Rα KO CD8 T cells were analyzed by gating on the respective congenic marker. Data are representative of at least two independent experiments with three to five mice per group. Error bars depict the SEM. ns, not significant; \*\**P* \< 0.01; \*\*\**P* \<0.001 by Student's *t* test.](nihms-1508707-f0003){#F3}

![The expansion of CD8 T~VM~ cell after helminth infection is independent of cognate antigen. OT-I TCR transgenic cells were transferred intravenously into CD45.1^+^ congenic B6 mice. One day later the recipient mice either remained uninfected or were infected with *Hp*. Two weeks later, host T cells (CD8α^+^CD45.1^+^) and OT-I cells (CD8α^+^CD45.2^+^Vα2^+^Vβ5^+^) in the mesLN were analyzed as described in [Figure 2](#F2){ref-type="fig"}. Data are representative of two independent experiments with three to four mice per group. Error bars depict the SEM. \*\*\**P* \< 0.001 by Student's *t* test.](nihms-1508707-f0004){#F4}

![CD8 T~VM~ cells are sufficient to confer innate non-cognate protection against bacterial infection. B6 WT mice were infected with *Hp* and naïve (CD44^lo^) or CD8 T~VM~ (CD44^hi^CD49d^lo^)cells were sorted from the pooled mesLN and spleen 2 weeks later. A total of 2×10^6^ cells were transferred into naïve IFNγ KO recipients, which were infected with 2×10^5^ *Lm* the next day. Bacterial burden in liver and spleen was determined at day 3. Data were pooled from 2 independent experiments. Solid bar depicts mean. X indicates individual mice that had succumbed to infection prior to analysis. ns, not significant; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\*\**P* \< 0.0001 by one-way ANOVA.](nihms-1508707-f0005){#F5}
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